The global platelet rich plasma (PRP) market has experienced substantial expansion, reflecting a growing emphasis on regenerative medicine and minimally invasive treatment modalities. In 2034, the market reached USD 2,857.98 million, demonstrating a robust compound annual growth rate (CAGR) of 11.7% from 2025 to 2034. This growth trajectory is underpinned by rising chronic disease prevalence,...